RightEye Vision System

by RightEye  · Based in United States → — Revolutionizing healthcare with advanced eye-tracking technology.
Neurology Ophthalmology Physical Medicine & Rehab

Initial setup fee $10,000-$15,000; annual fee $2,500-$5,000 (as of 2019).
Regulatory Status Disclosed

Overview

The RightEye Vision System is a portable, non-invasive eye-tracking system designed to objectively measure and analyze eye movements with high precision. Utilizing high-speed cameras and sophisticated software, it captures thousands of data points per second to provide detailed insights into visual function and neurological health. The system generates easy-to-understand, objective reports that help healthcare providers identify abnormalities or irregularities in eye movement, fixation, and response to visual stimuli. It offers customizable testing protocols and a cloud-based platform for managing patient data and tracking progress over time. The RightEye Dynamic Vision Trainer™ also provides online oculomotor training programs to help improve identified impairments.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • High-speed eye-tracking cameras
  • Advanced software analysis
  • Objective, quantitative data and reports
  • 5-minute, non-invasive assessments
  • Real-time results and comprehensive reports
  • Customizable testing protocols
  • Cloud-based software platform
  • EyeQ Trainer for oculomotor training
  • Measures various eye movements (saccades, smooth pursuits, fixation)
  • Compares patient results to age-based reference data

Use Cases

  • Diagnosing functional vision problems
  • Concussion and Traumatic Brain Injury (TBI) assessment
  • Identifying reading and learning difficulties
  • Sports vision training and performance optimization
  • Neurological screening (e.g., Parkinson's disease, with FDA warning regarding off-label promotion)
  • Vision therapy and rehabilitation

What Physicians Need to Know

Neurodegenerative Disease Screening
RightEye Vision System can detect signs of neurological disorders like Parkinson's disease by analyzing eye movements, potentially aiding in earlier detection. It identifies ocular tremors that may precede other common symptoms of Parkinson's. The system has received FDA Breakthrough Device Designation for its potential to aid in the assessment of Parkinson's disease. The technology is also used in research to understand early indicators for neurological issues and to develop new treatment options.
Brain MRI/CT Analysis
RightEye Vision System provides objective data about brain function in real-time by analyzing eye movements, even when traditional imaging like MRI or CT scans appear normal.
Concussion and Traumatic Brain Injury Assessment
The system is designed to assist in the detection, evaluation, and monitoring of brain-related dysfunctions, including traumatic brain injuries (TBI) and concussions. It can identify subtle abnormalities in eye movements that may indicate neurological dysfunction associated with concussions and post-concussion syndrome. RightEye helps track recovery over time and develop personalized treatment plans for individuals with brain injuries.
Assessment Speed
Screenings can be conducted in less than 30 seconds by a technician. A full automated sensorimotor exam can be run in less than five minutes. The test is quick, non-invasive, and typically takes only a few minutes to complete. The system records eye movements in real-time and generates results shortly after the assessment.
Objective Data and Reporting
RightEye provides objective, measurable data on eye movements, which helps in diagnosing conditions and monitoring treatment success. It generates detailed reports with visual maps and graphs that show eye movement patterns and performance. This objective data removes guesswork from treatment planning and allows for tracking progress over time.
Eye Movement Analysis
The system uses infrared eye-tracking technology to record, view, and analyze indiscernible eye movements. It tracks various eye movements, including saccades (quick movements), smooth pursuits (tracking moving objects), and fixation (steady gaze). The technology captures thousands of data points per second to precisely analyze eye movement behavior.
FDA Clearance
The RightEye Vision System is FDA-cleared for recording, viewing, and analyzing eye movements to identify visual tracking impairment in human subjects.
Physician Tip

The RightEye Vision System offers an objective and efficient way to assess eye movements, which are closely linked to brain function. Consider using it for early detection of neurodegenerative diseases like Parkinson's, as it can identify subtle ocular tremors. It's also valuable for evaluating and monitoring patients with concussions and traumatic brain injuries, providing data that traditional imaging might miss. The quick, non-invasive nature of the test makes it suitable for a wide range of patients, including children. The detailed reports can aid in developing personalized treatment plans and tracking patient progress over time.

RightEye combines its software solution with Tobii eye-tracking hardware to analyze eye movement behavior. The system is designed to integrate seamlessly into existing practice workflows. It utilizes a cloud-based platform for data processing and report generation.

Details

Category Neurology AI, Ophthalmology AI
Pricing Initial setup fee $10,000-$15,000; annual fee $2,500-$5,000 (as of 2019).
DeploymentOn-premise hardware (Tobii Dynavox i15) with cloud-based software, runs on Windows 10.
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Neurology, Ophthalmology, Physical Medicine & Rehab

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2018-09-28K181771 510(k)RightEye Vision System

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate RightEye Vision System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for RightEye Vision System.

View all on YouTube

Frequently Asked Questions

The RightEye Vision System uses high-speed cameras and AI-powered software to track and analyze eye movements, providing objective data on visual tracking, saccades, smooth pursuits, and fixation stability. This data can reveal functional vision problems linked to neurological conditions, concussions, traumatic brain injuries, and visual processing difficulties, offering insights beyond standard eye exams.
The RightEye Vision System is FDA-cleared for "recording, viewing, and analyzing eye movements in support of identifying visual tracking impairment in human subjects." However, the FDA has issued warnings regarding the promotion of the device for broader neurological disorders, including Parkinson's disease, ADHD, or mild traumatic brain injury, as this constitutes off-label use without specific clearance or approval for those indications. The system is a Class II Nystagmograph medical device.
Yes, the RightEye Vision System has not been cleared by the FDA to aid in the assessment or diagnosis of neurodevelopmental conditions like ADHD, mild traumatic brain injury (mTBI) or concussion, or neurodegenerative diseases such as Parkinson's disease. The FDA has stated that promoting the device for these conditions constitutes off-label use and raises safety concerns due to potential misdiagnosis or delayed treatment.
While the RightEye Vision System is a prominent eye-tracking technology, other AI-powered clinical decision support tools exist in neurology. These include platforms focused on neuroimaging analysis for stroke (e.g., Viz.ai, RapidAI), clinical decision support for complex differentials (e.g., MedLink AI), and ambient AI scribing (e.g., DeepCura AI/FreedAI). Some companies also offer AI-powered eye therapy devices for various visual disorders and rehabilitation after brain injury.
The RightEye Sensorimotor System has an MSRP of $18,994, with promotional offers sometimes reducing the price. It is insurance-reimbursable under CPT Code 92060 for sensorimotor exams through Medicare/Medicaid and major medical and vision insurance plans. This CPT code covers a quantitative sensorimotor examination with multiple measurements of ocular deviation, interpretation, and report.
The RightEye Vision System uses advanced eye-tracking technology and a cloud-based platform to collect over a billion data points from individuals, including measures of eye alignment, object tracking, depth perception, and dynamic visual acuity. This extensive dataset, combined with machine learning algorithms, helps identify eye-movement patterns that may be early indicators for neurological disorders like traumatic brain injury and Parkinson's disease. The system measures saccades, smooth pursuits, and fixation stability, which are all linked to brain function.
The RightEye Vision System generates detailed, objective reports that include visual maps and graphs of eye movement data. These reports highlight areas of concern and provide quantifiable metrics on visual performance, aiding physicians in making more informed diagnostic and treatment decisions for conditions linked to neurological function.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-12 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.